The National Comprehensive Cancer Network (NCCN) guidelines are the gold standard in hereditary cancer risk assessment, screening, and treatment. A minority of physicians follow NCCN guidelines for BRCA1 or BRCA2 mutations. This study assesses the impact of an interventional educational program on HBOC in terms of knowledge. Physicians were sent an invite to join either an intervention survey (web-training offered prior to the knowledge survey) or control survey (web-training offered after the knowledge survey). Sixty-nine physicians in the intervention arm and 67 physicians in the control arm completed the survey. The interventional group regularly answered items correctly at a higher frequency than the control group. For example, 64.71% (...
Background: Cancer genetic testing guides disease surveillance in those with moderate to high cancer...
Identification of risk for the hereditary breast and ovarian cancer syndrome (HBOC) is important, as...
Background: There is an underuse of genetic testing in breast cancer patients with a lower level of ...
Genetic counseling and testing is important for families with a strong history of breast and ovarian...
The Michigan Department of Health and Human Services implemented and evaluated two initiatives desig...
Hereditary breast and ovarian cancer (HBOC) is an inherited cancer syndrome that is associated with ...
Background: Cancer genetics have gained public attention dramatically. Everyday physicians and nurse...
The discovery of the breast and ovarian cancer predisposition genes, BRCA1 and BRCA2, has led to the...
Approved May 2017 by the faculty of UMKC in partial fulfillment of the requirements for the degree ...
The increasing use of genetic testing for BRCA1/2 and other pathogenic variants in the management of...
BACKGROUND: Genetic testing for cancer susceptibility is an emerging technology in medicine. This st...
Background: It has been suggested that primary care should become more involved in providing genetic...
(1) Background: Most common hereditary cancers in Europe have been associated with lifestyle behavio...
BACKGROUND: It has been suggested that primary care should become more involved in providing genetic...
PURPOSE: To examine referral source to cancer genetic services; communication of results of genetic ...
Background: Cancer genetic testing guides disease surveillance in those with moderate to high cancer...
Identification of risk for the hereditary breast and ovarian cancer syndrome (HBOC) is important, as...
Background: There is an underuse of genetic testing in breast cancer patients with a lower level of ...
Genetic counseling and testing is important for families with a strong history of breast and ovarian...
The Michigan Department of Health and Human Services implemented and evaluated two initiatives desig...
Hereditary breast and ovarian cancer (HBOC) is an inherited cancer syndrome that is associated with ...
Background: Cancer genetics have gained public attention dramatically. Everyday physicians and nurse...
The discovery of the breast and ovarian cancer predisposition genes, BRCA1 and BRCA2, has led to the...
Approved May 2017 by the faculty of UMKC in partial fulfillment of the requirements for the degree ...
The increasing use of genetic testing for BRCA1/2 and other pathogenic variants in the management of...
BACKGROUND: Genetic testing for cancer susceptibility is an emerging technology in medicine. This st...
Background: It has been suggested that primary care should become more involved in providing genetic...
(1) Background: Most common hereditary cancers in Europe have been associated with lifestyle behavio...
BACKGROUND: It has been suggested that primary care should become more involved in providing genetic...
PURPOSE: To examine referral source to cancer genetic services; communication of results of genetic ...
Background: Cancer genetic testing guides disease surveillance in those with moderate to high cancer...
Identification of risk for the hereditary breast and ovarian cancer syndrome (HBOC) is important, as...
Background: There is an underuse of genetic testing in breast cancer patients with a lower level of ...